Jones Financial Companies
COYA icon

Jones Financial Companies’s Coya Therapeutics COYA Stock Holding History

Jones Financial Companies’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$610K Buy
110,910
+65,950
+147% +$305K ﹤0.01% 2134
2026
Q1 		$178K Buy
44,960
+39,883
+786% +$186K ﹤0.01% 2448
2025
Q4 		$29.4K Buy
+5,077
New +$30.9K ﹤0.01% 2768
2025
Q1 		– Sell
-600
Closed -$3.44K – 3741
2024
Q4 		$3.44K Sell
600
-5,450
-90% -$37.1K ﹤0.01% 2866
2024
Q3 		$40.9K Buy
+6,050
New +$38.2K ﹤0.01% 1715

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Jones Financial Companies's COYA Position: Q2 2026 in Review

Jones Financial Companies increased its Coya Therapeutics (COYA) stake by 147% in Q2 2026, buying an estimated $305K and bringing the position to 110,910 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Jones Financial Companies first reported a position in COYA in Q3 2024 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Jones Financial Companies held 110,910 shares of Coya Therapeutics worth $610K as of Q2 2026.
  • Jones Financial Companies bought 65,950 Coya Therapeutics shares in Q2 2026, an estimated $305K.
  • Coya Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2134 holding.
  • Jones Financial Companies first reported a position in Coya Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.